The ErbB3 binding protein EBP1 regulates ErbB2 protein levels and tamoxifen sensitivity in breast cancer cells

Breast Cancer Research and Treatment

Volumn 126, Issue 1, 2011, Pages 27-36

  Lu, Yan ^a,b   Zhou, Hua ^a   Chen, Wantao ^b   Zhang, Yuexing ^a   Hamburger, Anne W ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Breast cancer; EBP1; ErbB2; Tamoxifen

Indexed keywords

BINDING PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 3 BINDING PROTEIN; ESTROGEN RECEPTOR; MESSENGER RNA; TAMOXIFEN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; DRUG SENSITIVITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; KNOCKOUT MOUSE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; TISSUE LEVEL; UBIQUITINATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BLOTTING, WESTERN; BREAST NEOPLASMS; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LUCIFERASES; MICE; MICE, KNOCKOUT; RECEPTOR, ERBB-2; RECEPTOR, ERBB-3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA-BINDING PROTEINS; TAMOXIFEN;

EID: 79251519290     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-0873-4     Document Type: Article

References (44)

1. T Holbro G Civenni NE Hynes 2003 The ErbB receptors and their role in cancer progression Exp Cell Res 284 99 110 1:CAS:528:DC%2BD3sXitVylt7o%3D 10.1016/S0014-4827(02)00099-X 12648469 (Pubitemid 36331969)
2. NE Hynes HA Lane 2005 ERBB receptors and cancer: the complexity of targeted inhibitors Nat Rev Cancer 5 341 354 1:CAS:528:DC%2BD2MXjslertb0%3D 10.1038/nrc1609 15864276 (Pubitemid 40637826)
3. DJ Slamon W Godolphin LA Jones JA Holt SG Wong DE Keith WJ Levin SG Stuart J Udove A Ullrich 1989 Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer Science 244 707 712 1:STN:280:DyaL1M3kt1Wntg%3D%3D 10.1126/science.2470152 2470152 (Pubitemid 19147683)
4. NR Lemoine DM Barnes DP Hollywood CM Hughes P Smith E Dublin SA Prigent WJ Gullick HC Hurst 1992 Expression of the ERBB3 gene product in breast cancer Br J Cancer 66 1116 1121 1:STN:280:DyaK3s%2FptVKksA%3D%3D 10.1038/bjc.1992.420 1333787 (Pubitemid 23006153)
5. SM Wiseman N Makretsov TO Nielsen B Gilks E Yorida M Cheang D Turbin K Gelmon DG Huntsman 2005 Coexpression of the type 1 growth factor receptor family members HER-1, HER-2, and HER-3 has a synergistic negative prognostic effect on breast carcinoma survival Cancer 103 1770 1777 1:CAS:528:DC%2BD2MXktFGnsb0%3D 10.1002/cncr.20970 15770691 (Pubitemid 40563247)
6. NV Sergina M Rausch D Wang J Blair B Hann KM Shokat MM Moasser 2007 Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3 Nature 445 437 441 1:CAS:528:DC%2BD2sXos12msA%3D%3D 10.1038/nature05474 17206155 (Pubitemid 46160912)
7. R Pinkas-Kramarski L Soussan H Waterman G Levkowitz I Alroy L Klapper S Lavi R Seger BJ Ratzkin M Sela Y Yarden 1996 Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions EMBO J 15 2452 2467 1:CAS:528:DyaK28XjsVGjurY%3D 8665853 (Pubitemid 26151185)
8. T Holbro RR Beerli F Maurer M Koziczak CF Barbas III NE Hynes 2003 The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation Proc Natl Acad Sci USA 100 8933 8938 1:CAS:528:DC%2BD3sXlvVyitbY%3D 10.1073/pnas.1537685100 12853564 (Pubitemid 36899201)
9. PL Bedard OC Freedman A Howell M Clemons 2008 Overcoming endocrine resistance in breast cancer: are signal transduction inhibitors the answer? Breast Cancer Res Treat 108 307 317 1:CAS:528:DC%2BD1cXjsFGisb4%3D 10.1007/s10549-007-9606-8 18351454 (Pubitemid 351431070)
10. MJ Piccart-Gebhart M Procter B Leyland-Jones A Goldhirsch M Untch I Smith L Gianni J Baselga R Bell C Jackisch D Cameron M Dowsett CH Barrios G Steger CS Huang M Andersson M Inbar M Lichinitser I Lang U Nitz H Iwata C Thomssen C Lohrisch TM Suter J Ruschoff T Suto V Greatorex C Ward C Straehle E McFadden MS Dolci RD Gelber 2005 Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer N Engl J Med 353 1659 1672 1:CAS:528:DC%2BD2MXhtFansr3L 10.1056/NEJMoa052306 16236737 (Pubitemid 41464705)
11. RJ Pietras J Arboleda DM Reese N Wongvipat MD Pegram L Ramos CM Gorman MG Parker MX Sliwkowski DJ Slamon 1995 HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells Oncogene 10 2435 2446 1:CAS:528:DyaK2MXmsFCgtr4%3D 7784095
12. CC Benz GK Scott JC Sarup RM Johnson D Tripathy E Coronado HM Shepard CK Osborne 1992 Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu Breast Cancer Res Treat 24 85 95 1:STN:280:DyaK3s7osVentQ%3D%3D 10.1007/BF01961241 8095168 (Pubitemid 23063891)
13. MH Kraus W Issing T Miki NC Popescu SA Aaronson 1989 Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors Proc Natl Acad Sci USA 86 9193 9197 1:CAS:528:DyaK3cXhtlenu7Y%3D 10.1073/pnas.86.23.9193 2687875 (Pubitemid 20010391)
14. GD Plowman GS Whitney MG Neubauer JM Green VL McDonald GJ Todaro M Shoyab 1990 Molecular cloning and expression of an additional epidermal growth factor receptor-related gene Proc Natl Acad Sci USA 87 4905 4909 1:CAS:528: DyaK3cXmtVGrsL4%3D 10.1073/pnas.87.13.4905 2164210 (Pubitemid 20224240)
15. JY Yoo XW Wang AK Rishi T Lessor XM Xia TA Gustafson AW Hamburger 2000 Interaction of the PA2G4 (EBP1) protein with ErbB-3 and regulation of this binding by heregulin Br J Cancer 82 683 690 1:CAS:528:DC%2BD3cXht1eisbY%3D 10.1054/bjoc.1999.0981 10682683 (Pubitemid 30085208)
16. TJ Lessor JY Yoo X Xia N Woodford AW Hamburger 2000 Ectopic expression of the ErbB-3 binding protein ebp1 inhibits growth and induces differentiation of human breast cancer cell lines J Cell Physiol 183 321 329 1:CAS:528: DC%2BD3cXivFWjsLc%3D 10.1002/(SICI)1097-4652(200006)183:3<321::AID-JCP4>3. 0.CO;2-O 10797306 (Pubitemid 30243862)
17. X Xia A Cheng T Lessor Y Zhang AW Hamburger 2001 Ebp1, an ErbB-3 binding protein, interacts with Rb and affects Rb transcriptional regulation J Cell Physiol 187 209 217 1:CAS:528:DC%2BD3MXisFWnsL4%3D 10.1002/jcp.1075 11268000 (Pubitemid 32270079)
18. YX Zhang N Woodford XM Xia AW Hamburger 2003 Repression of E2F1-mediated transcription by the ErbB3 binding protein Ebp1 involves histone deacetylases Nucl Acids Res 31 2168 2177 1:CAS:528:DC%2BD3sXivFCisL0%3D 10.1093/nar/gkg318 12682367 (Pubitemid 37442084)
19. Y Zhang AW Hamburger 2004 Heregulin regulates the ability of the ErbB3-binding protein Ebp1 to bind E2F promoter elements and repress E2F-mediated transcription J Biol Chem 279 26126 26133 1:CAS:528: DC%2BD2cXkvVWhu7g%3D 10.1074/jbc.M314305200 15073182 (Pubitemid 38798757)
20. Y Zhang D Akinmade AW Hamburger 2005 The ErbB3 binding protein Ebp1 interacts with Sin3A to repress E2F1 and AR-mediated transcription Nucl Acids Res 33 6024 6033 1:CAS:528:DC%2BD2MXht1Omt7zK 10.1093/nar/gki903 16254079 (Pubitemid 41742621)
21. Y Zhang D Akinmade AW Hamburger 2008 Inhibition of heregulin mediated MCF-7 breast cancer cell growth by the ErbB3 binding protein EBP1 Cancer Lett 265 298 306 1:CAS:528:DC%2BD1cXmtlWhsbg%3D 10.1016/j.canlet.2008.02.024 18355957
22. Y Zhang D Linn Z Liu J Melamed F Tavora CY Young AM Burger AW Hamburger 2008 EBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistance Mol Cancer Ther 7 3176 3186 1:CAS:528:DC%2BD1cXht1ensb7P 10.1158/1535-7163.MCT-08-0526 18852121
23. JS Zhang A Gong JC Cheville DI Smith CY Young 2005 AGR2, an androgen-inducible secretory protein overexpressed in prostate cancer Genes Chromosomes Cancer 43 249 259 1:CAS:528:DC%2BD2MXkslemur4%3D 10.1002/gcc.20188 15834940 (Pubitemid 40726870)
24. Y Zhang XW Wang D Jelovac T Nakanishi MH Yu D Akinmade O Goloubeva DD Ross A Brodie AW Hamburger 2005 The ErbB3-binding protein Ebp1 suppresses androgen receptor-mediated gene transcription and tumorigenesis of prostate cancer cells Proc Natl Acad Sci USA 102 9890 9895 1:CAS:528:DC%2BD2MXmsFaru70%3D 10.1073/pnas.0503829102 15994225 (Pubitemid 40993663)
25. DG Johnson K Ohtani JR Nevins 1994 Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression Genes Dev 8 1514 1525 1:CAS:528:DyaK2cXlvFOntbc%3D 10.1101/gad.8.13.1514 7958836 (Pubitemid 24218286)
26. Y Zhang Y Lu H Zhou M Lee Z Liu BA Hassel AW Hamburger 2008 Alterations in cell growth and signaling in ErbB3 binding protein-1 (Ebp1) deficient mice BMC Cell Biol 9 69 10.1186/1471-2121-9-69 19094237
27. W Xu M Marcu X Yuan E Mimnaugh C Patterson L Neckers 2002 Chaperone-dependent E3 ubiquitin ligase CHIP mediates a degradative pathway for c-ErbB2/Neu Proc Natl Acad Sci USA 99 12847 12852 1:CAS:528:DC%2BD38XnvFGhsbY%3D 10.1073/pnas.202365899 12239347
28. Z Liu SM Oh M Okada X Liu D Cheng J Peng DJ Brat SY Sun W Zhou W Gu K Ye 2009 Human BRE1 is an E3 ubiquitin ligase for Ebp1 tumor suppressor Mol Biol Cell 20 757 768 1:CAS:528:DC%2BD1MXisVSnsro%3D 10.1091/mbc.E08-09-0983 19037095
29. LN Klapper H Waterman M Sela Y Yarden 2000 Tumor-inhibitory antibodies to HER-2/ErbB-2 may act by recruiting c-Cbl and enhancing ubiquitination of HER-2 Cancer Res 60 3384 3388 1:CAS:528:DC%2BD3cXkvFChsro%3D 10910043 (Pubitemid 30482151)
30. TP Monie AJ Perrin JR Birtley TR Sweeney I Karakasiliotis Y Chaudhry LO Roberts S Matthews IG Goodfellow S Curry 2007 Structural insights into the transcriptional and translational roles of Ebp1 EMBO J 26 3936 3944 1:CAS:528:DC%2BD2sXpvFWhsLw%3D 10.1038/sj.emboj.7601817 17690690 (Pubitemid 47367486)
31. H Yamada H Mori H Momoi Y Nakagawa C Ueguchi T Mizuno 1994 A fission yeast gene encoding a protein that preferentially associates with curved DNA Yeast 10 883 894 1:CAS:528:DyaK2cXmt1egt7s%3D 10.1002/yea.320100704 7985416 (Pubitemid 24235065)
32. N Radomski E Jost 1995 Molecular cloning of a murine cDNA encoding a novel protein, p38-2G4, which varies with the cell cycle Exp Cell Res 220 434 445 1:CAS:528:DyaK2MXosVOrtbk%3D 10.1006/excr.1995.1335 7556453
33. M Squatrito M Mancino L Sala GF Draetta 2006 Ebp1 is a dsRNA-binding protein associated with ribosomes that modulates eIF2alpha phosphorylation Biochem Biophys Res Commun 344 859 868 1:CAS:528:DC%2BD28XktVOqtr0%3D 10.1016/j.bbrc.2006.03.205 16631606
34. M Squatrito M Mancino M Donzelli LB Areces GF Draetta 2004 EBP1 is a nucleolar growth-regulating protein that is part of pre-ribosomal ribonucleoprotein complexes Oncogene 23 4454 4465 1:CAS:528:DC%2BD2cXksFSgs70%3D 10.1038/sj.onc.1207579 15064750 (Pubitemid 38850424)
35. SK Bose TK Sengupta S Bandyopadhyay EK Spicer 2006 Identification of Ebp1 as a component of cytoplasmic bcl-2 mRNP (messenger ribonucleoprotein particle) complexes Biochem J 396 99 107 1:CAS:528:DC%2BD28XjvFSls74%3D 10.1042/BJ20051548 16396631 (Pubitemid 43764501)
36. EV Pilipenko TV Pestova VG Kolupaeva EV Khitrina AN Poperechnaya VI Agol CU Hellen 2000 A cell cycle-dependent protein serves as a template-specific translation initiation factor Genes Dev 14 2028 2045 1:CAS:528: DC%2BD3cXmtFShu70%3D 10950867 (Pubitemid 30637353)
37. JY Ahn X Liu Z Liu L Pereira D Cheng J Peng PA Wade AW Hamburger K Ye 2006 Nuclear Akt associates with PKC-phosphorylated Ebp1, preventing DNA fragmentation by inhibition of caspase-activated DNase EMBO J 25 2083 2095 1:CAS:528:DC%2BD28Xks1ajsro%3D 10.1038/sj.emboj.7601111 16642037 (Pubitemid 43756225)
38. M Okada SW Jang K Ye 2007 Ebp1 association with nucleophosmin/B23 is essential for regulating cell proliferation and suppressing apoptosis J Biol Chem 282 36744 36754 1:CAS:528:DC%2BD2sXhsVSgt7%2FF 10.1074/jbc.M706169200 17951246
39. D Akinmade M Lee Y Zhang AW Hamburger 2007 Ebp1-mediated inhibition of cell growth requires serine 363 phosphorylation Int J Oncol 31 851 858 1:CAS:528:DC%2BD2sXht1SjurbL 17786317
40. Z Liu X Liu KI Nakayama K Nakayama K Ye 2007 Protein kinase C-delta phosphorylates Ebp1 and prevents its proteolytic degradation, enhancing cell survival J Neurochem 100 1278 1288 1:CAS:528:DC%2BD2sXjt1Grsro%3D 10.1111/j.1471-4159.2006.04313.x 17316401 (Pubitemid 46246411)
41. HR Qin D Iliopoulos T Nakamura S Costinean S Volinia T Druck J Sun H Okumura K Huebner 2007 Wwox suppresses prostate cancer cell growth through modulation of ErbB2-mediated androgen receptor signaling Mol Cancer Res 5 957 965 1:CAS:528:DC%2BD2sXhtVaktrvK 10.1158/1541-7786.MCR-07-0211 17704139 (Pubitemid 47416672)
42. MB Laederich M Funes-Duran L Yen E Ingalla X Wu KL Carraway III C Sweeney 2004 The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases J Biol Chem 279 47050 47056 1:CAS:528:DC%2BD2cXptFejsLk%3D 10.1074/jbc.M409703200 15345710 (Pubitemid 39518360)
43. Z Liu JY Ahn X Liu K Ye 2006 Ebp1 isoforms distinctively regulate cell survival and differentiation Proc Natl Acad Sci USA 103 10917 10922 1:CAS:528:DC%2BD28XnsFGqsb4%3D 10.1073/pnas.0602923103 16832058 (Pubitemid 44148395)
44. A Hurtado KA Holmes TR Geistlinger IR Hutcheson RI Nicholson M Brown J Jiang WJ Howat S Ali JS Carroll 2008 Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen Nature 456 663 666 1:CAS:528:DC%2BD1cXhsVGlur7E 10.1038/nature07483 19005469